Heroin and cocaine use worry EU drugs agency

Bookmark and Share

By Martin Banks
- 7th November 2008
We have to take these warnings very seriously because this is a growing problem, with between 7000 and 8000 people dying from drug-related incidents every year

Belgian ALDE MEP Gérard Deprez

The EU drugs agency has voiced concern about the “glut” of heroin available in Europe in a major new report published on Thursday.

The report says stimulant drugs, such as amphetamines, ecstasy and cocaine, are the second most commonly consumed drug type in Europe today, after cannabis.

But the report, ‘The state of the drugs problem in Europe’, reveals a “very mixed picture” within this group in terms of prevalence, trends and market developments.

It says some 12 million Europeans (aged 15-64 years) have tried cocaine in their lifetime, compared with around 11 million for amphetamines and 9.5 million for ecstasy.

While the latest European data confirms reports of a stabilisation or even declining trend in the use of amphetamines and ecstasy, they point to a continued rise in cocaine use, albeit in a limited number of countries.

The annual report of the European monitoring centre for drugs and drug addiction (EMCDDA) also found “signs of change” in Europe ’s heroin problem, which, says the agency, means that countries need to be vigilant and prepared to respond.

The Lisbon-based EMCDDA estimates that there are between 1.3 and 1.7 million problem opioid users in the EU and Norway, with heroin responsible for Europe’s largest drug-related health and social costs.

The report questions previous EMCDDA assessments of a slowly improving heroin situation and points to a “stable but no longer diminishing problem”.

Record opium production in Afghanistan in 2007 has also heightened the agency’s worries over a potential knock-on effect on Europe’s heroin problem.

Speaking at a news conference in parliament on Thursday, EMCDDA director Wolfgang Gotz said, “We cannot ignore the threat posed by the glut of heroin now available on the world market. Vigilance is clearly required.

“But to ensure that Europe is ready to respond rapidly, there is a critical need to improve the sensitivity of our information systems to changes in the availability and use of these most damaging substances.”

His comments were echoed by Belgian ALDE MEP Gérard Deprez, chairman of the civil liberties committee, which is responsible for monitoring drug action programmes in member states. “We have to take these warnings very seriously because this is a growing problem, with between 7000 and 8000 people dying from drug-related incidents every year.”

Bookmark and Share

Have your say...

Please enter your comments below.

Name

Your e-mail address


Listen to audio version

Please type in the letters or numbers shown above (case sensitive)

Related News

MEP calls for health treatment to switch from 'treatment to prevention'

EU urged to do more to promote missing children hotline

EU efforts to improve food safety hailed a 'big success'

Member states urged to do more to tackle chronic disease

Public private partnerships key to growth of EU pharma research



Latest news

MEPs overwhelmingly back resolution on gay rights

Parliament has overwhelmingly adopted a resolution to condemn homophobic laws and discrimination in Europe


MEP calls for health treatment to switch from 'treatment to prevention'

A conference in Brussels heard that 40 per cent of Europeans aged over 15 have a chronic disease


MEPs call for 'tuna sanctuaries' to help preserve stocks

Parliament has adopted new legislation, implementing internationally-agreed rules on bluefin tuna fishing


EU urged to do more to promote missing children hotline


MEPs hit out at attempts to 'water down' code of conduct


Taiwan steps up campaign to become full WHA member


Parliament endorses EU-wide FTT


EU leaders urged to reject 'failed' austerity measures


More from Dods